A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve

Status: Recruiting
Location: See all (20) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this study is to learn what effects the ABC Bicuspid Sizing Algorithm has on the clinical outcomes of patients with bicuspid aortic stenosis after having a transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. The main questions the study aims to answer are: 1. Does the ABC Bicuspid Sizing Algorithm increase the technical success at exit from the procedure room? 2. Does the ABC Bicuspid Sizing Algorithm increase the device success at 30 days after the procedure? Participants already being evaluated for a TAVR as part of their regular medical care for bicuspid aortic stenosis will have their diagnostic images assessed using the ABC Bicuspid Sizing Algorithm to help determine their procedure type and valve size. They will have visits 30 days and one year after their procedure.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Have bicuspid aortic valve disease

• Have severe aortic stenosis or mixed aortic stenosis and regurgitation requiring treatment

• Have no other condition requiring surgical intervention

• Have had a TAVR CT scan (retrospectively gated contrast enhanced acquisition) that is of diagnostic quality and includes multiphase reconstructions of the aortic root at the minimum available slice thickness (with at least three systolic and one diastolic phases)

• Would be treated with a Sapien 3 valve if found to be anatomically suitable for TAVR

• Have a suitable access route for TAVR with a Sapien 3 valve

Locations
Other Locations
Australia
The Prince Charles Hospital
NOT_YET_RECRUITING
Chermside
The Alfred
NOT_YET_RECRUITING
Melbourne
Fiona Stanley Hospital
NOT_YET_RECRUITING
Murdoch
John Hunter Hospital
NOT_YET_RECRUITING
New Lambton Heights
St Andrew's War Memorial Hospital
NOT_YET_RECRUITING
Spring Hill
North Shore Private Hospital
NOT_YET_RECRUITING
St Leonards
Royal North Shore Hospital
NOT_YET_RECRUITING
St Leonards
Canada
Foothills Medical Centre
NOT_YET_RECRUITING
Calgary
Hamilton General Hospital
RECRUITING
Hamilton
Southlake Regional Health Centre
NOT_YET_RECRUITING
Newmarket
University of Ottawa Heart Institute
NOT_YET_RECRUITING
Ottawa
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
NOT_YET_RECRUITING
Québec
St. Michael's Hospital
NOT_YET_RECRUITING
Toronto
Colombia
Fundación Cardioinfantil - LaCardio
NOT_YET_RECRUITING
Bogotá
Costa Rica
Hospital San Juan de Dios
NOT_YET_RECRUITING
San José
Mexico
Centro Médico Nacional Siglo XXI
NOT_YET_RECRUITING
Ciudad De México
Instituto Nacional de Cardiología - Ignacio Chávez
NOT_YET_RECRUITING
Ciudad De México
New Zealand
Wellington Regional Hospital
NOT_YET_RECRUITING
Newtown
Singapore
National Heart Centre Singapore
NOT_YET_RECRUITING
Singapore
Thailand
Ramathibodi Hospital
NOT_YET_RECRUITING
Bangkok
Contact Information
Primary
Sarah Tawadros, MD
sarah.tawadros@worldhealthresearch.ca
289-768-8223
Time Frame
Start Date: 2025-05-13
Estimated Completion Date: 2027-12
Participants
Target number of participants: 290
Sponsors
Leads: World Health Research Inc.
Collaborators: Edwards Lifesciences

This content was sourced from clinicaltrials.gov